NEI
TEVA icon

Northwest & Ethical Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Northwest & Ethical Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.6K Buy
+39,900
New +$1.28M ﹤0.01% 519

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northwest & Ethical Investments's TEVA Position: Q1 2026 in Review

Northwest & Ethical Investments increased its Teva Pharmaceuticals (TEVA) stake by 32% in Q1 2026, buying an estimated $251K and bringing the position to 32,470 shares worth $968K. The position accounts for 0.02% of the portfolio, ranked #316.

Northwest & Ethical Investments first reported a position in TEVA in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.39M in Q3 2018. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Northwest & Ethical Investments held 32,470 shares of Teva Pharmaceuticals worth $968K as of Q1 2026.
  • Northwest & Ethical Investments bought 7,802 Teva Pharmaceuticals shares in Q1 2026, an estimated $251K.
  • Teva Pharmaceuticals made up 0.02% of Northwest & Ethical Investments's portfolio in Q1 2026, its #316 holding.
  • Northwest & Ethical Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
  • Northwest & Ethical Investments's Teva Pharmaceuticals position peaked at $2.39M in Q3 2018.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.